scispace - formally typeset
E

Edward G. Lakatta

Researcher at National Institutes of Health

Publications -  902
Citations -  95504

Edward G. Lakatta is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Blood pressure & Population. The author has an hindex of 146, co-authored 858 publications receiving 88637 citations. Previous affiliations of Edward G. Lakatta include University of Pittsburgh & University College London.

Papers
More filters
Journal ArticleDOI

Effects of acute beta-adrenergic receptor blockade on age-associated changes in cardiovascular performance during dynamic exercise.

TL;DR: In this article, the nonselective beta-adrenergic receptor blocker propranolol (0.15 mg/kg IV) was administered to 25 healthy normotensive men from the Baltimore Longitudinal Study of Aging (BLSA) immediately before maximal upright cycle ergometry with 99mTc gated cardiac blood pool scintigraphy.
Journal ArticleDOI

The ryanodine receptor modulates the spontaneous beating rate of cardiomyocytes during development

TL;DR: It is concluded that a functional RyR2 is crucial to the progressive increase in heart rate during differentiation of ES cell-derived cardiomyocytes, consistent with a mechanism that couples Ca2+ release via RyR before an action potential with activation of an inward current that accelerates membrane depolarization.
Journal ArticleDOI

Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities.

TL;DR: Out-of-office ambulatory peripheral blood pressure (SBP- 24 h) may be superior to central blood pressure in the prediction of cardiovascular mortality, but PP-C may better predict all-cause mortality than SBP-24 h or PP-24h.
Journal ArticleDOI

Beneficial Effects of Chronic Pharmacological Manipulation of β-Adrenoreceptor Subtype Signaling in Rodent Dilated Ischemic Cardiomyopathy

TL;DR: These results provide proof of concept for the efficacy of chronic &bgr;2AR stimulation in this DCM model and protect myocytes from death and thereby ameliorate cardiac remodeling in chronic heart failure.